
“The broader vision and mission of our study is to develop a minimally invasive blood test kit for early diagnostics, monitoring, and guiding therapeutic planning of triple-negative breast cancer patients.”
“The addition of these four ORs and hybrid OR suite will dramatically expand our ability to perform the most complex tertiary surgical procedures while also caring for our trauma patients.”
Stay up to date on the latest news from our providers, facilities and researchers at USA Health.
“The broader vision and mission of our study is to develop a minimally invasive blood test kit for early diagnostics, monitoring, and guiding therapeutic planning of triple-negative breast cancer patients.”
Mitchell Cancer Institute researchers analyzed the impact of remote symptom monitoring for cancer patients.
William Kilgo, M.D., applied the test to a diverse group of patients to determine the feasibility of its real-world application and concluded it is a reliable indicator of disease activity.
Jennifer Young Pierce, M.D., M.P.H., FACOG, is the director of the Division of Cancer Control and Prevention at the USA Health Mitchell Cancer Institute, where she conducts research in cancer care delivery and supportive care for cancer patients and survivors, and is a principal investigator on grants totaling $1.3 million.
The Mayer Mitchell Award for Excellence in Cancer Research was established in 2009 by USA trustee Arlene Mitchell in memory of her late husband, Mayer Mitchell, a formative figure in the establishment of the Mitchell Cancer Institute.
Data suggests many women experience negative effects from menopausal symptoms and often do not know how to seek support in the workplace – or they remain silent, fearing they will be stigmatized.
This research has the potential to cast light on mechanisms underlying the long-term health problems faced by patients' post-recovery from intensive care unit stays.
Bassam Bassam, M.D., says direct care of patients with neuromuscular diseases is the best way to understand illnesses, motivate research, and advance the field of neurological medicine, while training future neurologists in academic and clinical settings.
“Expanding the fellowship program to include hematology training will grow the fellows’ capability and opportunities for job placement after graduation,” said Omar Alkharabsheh, M.D.
“To address race-associated prostate cancer disparities, it is important first to understand how tumors from different races differ in their biology and molecular landscape,” said Ajay Singh, Ph.D.
Ovarian cancer ranks fifth in cancer deaths among women, accounting for more deaths than any other cancer of the female reproductive system. Only about 20% of cases are diagnosed at an early stage, when ovarian cancer is more treatable.
Annabelle Fonseca, M.D., M.H.S., said the research will focus on a systems-based approach to identify patients at risk of developing upper GI cancers and allow for early intervention and improvements to care.